Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Clin Neurol Neurosurg. 2024 Feb;237:108147. doi: 10.1016/j.clineuro.2024.108147. Epub 2024 Feb 2.
The unified multiple system atrophy rating scale (UMSARS) was used to evaluate various symptoms of multiple system atrophy (MSA). And UMSARS part 1 was originally developed for use in interviews, but the need for telemedicine is increasing in COVID-19 pandemic. The purpose of this study is to evaluate the reliability of the UMSARS part 1 telephone survey.
Thirty-two MSA patients took the UMSARS part 1 face-to-face, followed by two more telephone evaluations. Intraclass correlation coefficients (ICC) and Cronbach's alpha (α) coefficients were calculated, and the inter-rater reliability was determined. At the same time, we asked about the problems in COVID-19 pandemic.
The study participants included 15 men and 17 women with mean age of 67.1 years (SD, 8.3). For the total UMSARS part 1 score, the inter-rater ICC and Cronbach's α coefficient were 0.89 to 0.92, and 0.84 to 0.87, respectively. More than half of the items had a relatively high ICC. Cronbach's α coefficients were more than 0.7 for all items. Changes that occurred in COVID-19 pandemic included reduced outings and lack of rehabilitation in about half of the cases.
The UMSARS part 1 has high inter-rater reliability and internal consistency. Evaluation of subjective symptoms showed that some variability could occur. In addition, there was concern about the influence of lack of rehabilitation due to COVID-19 pandemic.
统一多系统萎缩评分量表(UMSARS)用于评估多系统萎缩(MSA)的各种症状。UMSARS 第 1 部分最初是为访谈而开发的,但在 COVID-19 大流行期间,远程医疗的需求日益增加。本研究旨在评估 UMSARS 第 1 部分电话调查的可靠性。
32 名 MSA 患者面对面接受 UMSARS 第 1 部分评估,然后再进行两次电话评估。计算了组内相关系数(ICC)和克朗巴赫α系数(α),并确定了评分者间信度。同时,我们询问了 COVID-19 大流行期间存在的问题。
研究参与者包括 15 名男性和 17 名女性,平均年龄为 67.1 岁(标准差,8.3)。对于 UMSARS 第 1 部分总分,评分者间 ICC 和克朗巴赫α系数分别为 0.89 至 0.92,以及 0.84 至 0.87。超过一半的项目具有相对较高的 ICC。所有项目的克朗巴赫α系数均大于 0.7。COVID-19 大流行期间发生的变化包括近一半的病例外出减少和康复缺乏。
UMSARS 第 1 部分具有较高的评分者间信度和内部一致性。对主观症状的评估表明,可能会出现一些变化。此外,人们担心 COVID-19 大流行导致康复缺乏的影响。